Showing results (11-20 of 78) with videos related to
Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|August 13, 2008
Enhanced bactericidal activity of rifampin and/or pyrazinamide when combined with PA-824 in a murine model of tuberculosisRokeya Tasneen, Sandeep Tyagi, Kathy Williams, et al.The Journal of Infectious Diseases|May 27, 2015
Nonclinical models for antituberculosis drug development: a landscape analysisTawanda Gumbo, Anne J Lenaerts, Debra Hanna, et al.Antimicrobial Agents and Chemotherapy|October 17, 2007
In vivo validation of the mutant selection window hypothesis with moxifloxacin in a murine model of tuberculosisDeepak Almeida, Eric Nuermberger, Sandeep Tyagi, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2015
Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic OutcomesTawanda Gumbo, Jotam G Pasipanodya, Klaus Romero, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2015
Systematic Analysis of Hollow Fiber Model of Tuberculosis ExperimentsJotam G Pasipanodya, Eric Nuermberger, Klaus Romero, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2015
Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and ConfirmTawanda Gumbo, Jotam G Pasipanodya, Eric Nuermberger, et al.Antimicrobial Agents and Chemotherapy|May 23, 2002
Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosisTetsuyuki Yoshimatsu, Eric Nuermberger, Sandeep Tyagi, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2016
Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children With Disseminated Tuberculosis: GoldilocksShashikant Srivastava, Devyani Deshpande, Jotam Pasipanodya, et al.Journal of Medical Microbiology|July 24, 2007
Activity of ketoconazole against Mycobacterium tuberculosis in vitro and in the mouse modelSean T Byrne, Steven M Denkin, Peihua Gu, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2016
Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic DuoDevyani Deshpande, Shashikant Srivastava, Eric Nuermberger, et al.Pageof 8